Novozymes As B Stock Market Value
| NVZMF Stock | USD 59.48 1.98 3.44% |
| Symbol | Novozymes |
Novozymes A/S 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novozymes A/S's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novozymes A/S.
| 06/04/2023 |
| 11/25/2024 |
If you would invest 0.00 in Novozymes A/S on June 4, 2023 and sell it all today you would earn a total of 0.00 from holding Novozymes AS B or generate 0.0% return on investment in Novozymes A/S over 540 days. Novozymes A/S is related to or competes with HUMANA, Barloworld, Morningstar Unconstrained, High-yield Municipal, Thrivent High, Via Renewables, and T Rowe. Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, N... More
Novozymes A/S Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novozymes A/S's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novozymes AS B upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 12.49 | |||
| Value At Risk | (4.50) | |||
| Potential Upside | 3.92 |
Novozymes A/S Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novozymes A/S's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novozymes A/S's standard deviation. In reality, there are many statistical measures that can use Novozymes A/S historical prices to predict the future Novozymes A/S's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | 0.0207 | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | 0.1016 |
Novozymes AS B Backtested Returns
Novozymes AS B has Sharpe Ratio of -0.0765, which conveys that the firm had a -0.0765% return per unit of risk over the last 3 months. Novozymes A/S exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novozymes A/S's Standard Deviation of 2.75, mean deviation of 2.0, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -1.08, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Novozymes A/S are expected to decrease slowly. On the other hand, during market turmoil, Novozymes A/S is expected to outperform it slightly. At this point, Novozymes AS B has a negative expected return of -0.21%. Please make sure to verify Novozymes A/S's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Novozymes AS B performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.48 |
Average predictability
Novozymes AS B has average predictability. Overlapping area represents the amount of predictability between Novozymes A/S time series from 4th of June 2023 to 29th of February 2024 and 29th of February 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novozymes AS B price movement. The serial correlation of 0.48 indicates that about 48.0% of current Novozymes A/S price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 22.87 |
Novozymes AS B lagged returns against current returns
Autocorrelation, which is Novozymes A/S pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Novozymes A/S's pink sheet expected returns. We can calculate the autocorrelation of Novozymes A/S returns to help us make a trade decision. For example, suppose you find that Novozymes A/S has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Novozymes A/S regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Novozymes A/S pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Novozymes A/S pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Novozymes A/S pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Novozymes A/S Lagged Returns
When evaluating Novozymes A/S's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Novozymes A/S pink sheet have on its future price. Novozymes A/S autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Novozymes A/S autocorrelation shows the relationship between Novozymes A/S pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Novozymes AS B.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Novozymes Pink Sheet
Novozymes A/S financial ratios help investors to determine whether Novozymes Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novozymes with respect to the benefits of owning Novozymes A/S security.